Skip to main content


Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting

Licensing Opportunities

 

Verified

Dr. Reddys FDFs - Licensing Opportunities

At Dr. Reddy's Laboratories, we are committed to enhancing our product portfolio and delivering innovative healthcare solutions to patients worldwide. Both in-licensing and out-licensing play crucial roles in our strategy to achieve these goals. By partnering with other companies, we can accelerate the development and commercialization of new treatments, optimize our portfolio, and extend the reach of our innovations.

Contact Us

In-licensing allows us to acquire rights to promising drug candidates and cutting-edge technologies from other companies. This process enables us to address unmet medical needs and improve patient outcomes by bringing new treatments to market more efficiently and effectively.

Our In-Licensing Process

Identification of Needs

We identify gaps in our product portfolio and areas where we need new technologies or compounds.

Search for Partners

Our business development team actively searches for potential partners with the desired assets.

Evaluation and Due Diligence

We conduct rigorous evaluations and due diligence to assess the potential value and risks associated with the assets.

Negotiation

We negotiate terms with the partner, including financial terms, development milestones, and royalty arrangements.

Agreement

A formal in-licensing agreement is drafted and signed, outlining the rights and responsibilities of both parties.

Regulatory Compliance

We ensure that all regulatory requirements are met for the development and commercialization of the in-licensed assets.

Development and Commercialization

Our research and development teams advance these products through the development pipeline.

Collaboration and Support

We maintain close communication with our partners, leveraging their expertise and support throughout the development and commercialization process.

Out-Licensing

Out-licensing is a strategic approach that allows us to partner with other companies to develop, manufacture, and commercialize our assets. This process extends the reach and impact of our innovative drug candidates and technologies.

Our Out-Licensing Process

We identify promising assets within our portfolio that are suitable for out-licensing.
Our business development team conducts comprehensive market research to identify potential partners.
Both Dr. Reddy's and the potential partners engage in thorough due diligence to evaluate the value and potential of the assets.
We negotiate terms with our partners, including financial compensation, development milestones, and royalty structures.
A formal out-licensing agreement is drafted and signed, outlining the rights and responsibilities of both parties.
We ensure regulatory compliance and work closely with our partners to meet all requirements.
Our partners take on the responsibility of developing, manufacturing, and marketing the out-licensed products.
We maintain close communication with our partners and monitor the progress and performance of the out-licensed assets.

Our Commitment to Innovation and Collaboration

At Dr. Reddy's, we believe in the power of collaboration to drive innovation in healthcare. Our in-licensing and out-licensing efforts are a testament to our dedication to delivering high-quality, affordable medicines and making a meaningful impact on global health. By partnering with other companies, we can bring new treatments to market more efficiently and effectively, ultimately benefiting patients around the world.

Contact Us

For more information or to discuss potential licensing opportunities, please contact our team at: api@drreddys.com.

We look forward to collaborating with you to advance healthcare and improve patient outcomes.

Disclaimer

No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.

Company

Contact Us

Follow Us on

  • Twitter

Dr. Reddy’s Laboratories, 8-2-337,
Banjara Hills Rd Number 3,
SBI Executive Enclave, Green Valley,
Banjara Hills, Hyderabad,
Telangana 500034
Phone: 040 4900 2222

© 2025 Dr. Reddy’s Laboratories Ltd. All rights reserved.

Dr. Reddy’s Laboratories, 8-2-337,
Banjara Hills Rd Number 3,
SBI Executive Enclave, Green Valley,
Banjara Hills, Hyderabad,
Telangana 500034
Phone: 040 4900 2222

  • Twitter

© 2025 Dr. Reddy’s Laboratories Ltd.
All rights reserved.